Relative roles of Th1 and Th17 effector cells in allograft rejection

Current Opinion in Organ Transplantation

Volumn 14, Issue 1, 2009, Pages 23-29

  Atalar, Kerem ^a,b   Afzali, Behdad ^a   Lord, Graham ^a,b,c   Lombardi, Giovanna ^a,b,d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

Allograft rejection; Human; T helper type 1; T helper type 17; Transplantation

Indexed keywords

GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 17;

ALLOGRAFT; CD4+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EFFECTOR CELL; GRAFT REJECTION; HUMAN; INTERFERON PRODUCTION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; ALLOTRANSPLANTATION; ANIMAL; CELL DIFFERENTIATION; DRUG EFFECT; GRAFT SURVIVAL; IMMUNOLOGY; METABOLISM; ORGAN TRANSPLANTATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TREATMENT OUTCOME;

ANIMALS; CELL DIFFERENTIATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKIN-17; ORGAN TRANSPLANTATION; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 67649210785     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32831b70c2     Document Type: Review

References (68)

1. Afzali B, Lechler RI, Hernandez-Fuentes MP. Allorecognition and the alloresponse: clinical implications. Tissue Antigens 2007; 69:545-556.
2. Mcgeachy M, Cua D. Th17 cell differentiation: the long and winding road. Immunity 2008; 28:445-453. A timely review that details the differences between human and murine Th17 differentiation and the way in which understanding of these processes has developed in recent years.
3. Weaver CT, Hatton RD, Mangan PR, Harrington LE. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007; 25:821-852.
4. Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000; 13:715-725.
5. Malfait AM, Butler DM, Presky DH, et al. Blockade of IL-12 during the induction of collagen-induced arthritis (CIA) markedly attenuates the severity of the arthritis. Clin Exp Immunol 1998; 111:377-383.
6. Gran B, Zhang GX, Yu S, et al. IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J Immunol 2002; 169:7104-7110. (Pubitemid 36899299)
7. Murphy CA, Langrish CL, Chen Y, et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003; 198:1951-1957. (Pubitemid 38032126)
8. Billiau A, Heremans H, Vandekerckhove F, et al. Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J Immunol 1988; 140:1506-1510. (Pubitemid 18103575)
9. Willenborg DO, Fordham S, Bernard CC, et al. IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996; 157:3223-3227. (Pubitemid 126449130)
10. Thakker P, Leach MW, Kuang W, et al. IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis. J Immunol 2007; 178:2589-2598. (Pubitemid 46233462)
11. Mosmann TR, Cherwinski H, Bond MW, et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986; 136:2348-2357.
12. Aggarwal S, Ghilardi N, Xie MH, et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 2003; 278:1910-1914. (Pubitemid 36801431)
13. Martín-Fontecha A, Thomsen L, Brett S, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004; 5:1260-1265. (Pubitemid 41057741)
14. Sawitzki B, Kingsley CI, Oliveira V, et al. IFN-gamma production by alloantigen- reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005; 201:1925-1935. (Pubitemid 41002929)
15. O'Connell PJ, Pacheco-Silva A, Nickerson PW, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150:1093-1104. (Pubitemid 23133690)
16. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174:493-496.
17. Nickerson P, Steurer W, Steiger J, et al. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994; 6:757-764.
18. Halloran PF, Miller LW, Urmson J, et al. IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol 2001; 166:7072-7081. (Pubitemid 32525576)
19. Miura M, El-Sawy T, Fairchild RL. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma. Am J Pathol 2003; 162:509-519. (Pubitemid 36267858)
20. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6:1123-1132.
21. Famulski KS, Sis B, Billesberger L, Halloran PF. Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm. Am J Transplant 2008; 8:547-556. (Pubitemid 351287549)
22. Gras J, Wieërs G, Vaerman JL, et al. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients. Liver Transpl 2007; 13:426-433. (Pubitemid 46444472)
23. Hauser IA, Spiegler S, Kiss E, et al. Prediction of acute renal allograft rejection by urinary monokine induced by IFN-gamma (MIG). J Am Soc Nephrol 2005; 16:1849-1858.
24. Sadeghi M, Daniel V, Naujokat C, et al. Evidence for IFN-gamma up- and IL-4 downregulation late posttransplant in patients with good kidney graft outcome. Clin Transplant 2007; 21:449-459. (Pubitemid 47161820)
25. Ghafari A, Makhdoomi K, Ahmadpour P, et al. Serum T-lymphocyte cytokines cannot predict early acute rejection in renal transplantation. Transplant Proc 2007; 39:958-961. (Pubitemid 46764867)
26. Hoffmann SC, Hale DA, Kleiner DE, et al. Functionally significant renal allograft rejection is defined by transcriptional criteria. Am J Transplant 2005; 5:573-581.
27. Townsend MJ, Weinmann AS, Matsuda JL, et al. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 2004; 20:477-494.
28. Garrett W, Lord G, Punit S, et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 2007; 131:33-45. (Pubitemid 47505255)
29. Alcaide P, Jones TG, Lord GM, et al. Dendritic cell expression of the transcription factor T-bet regulates mast cell progenitor homing to mucosal tissue. J Exp Med 2007; 204:431-439. (Pubitemid 46294557)
30. Van Kooten C, Boonstra JG, Paape ME, et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998; 9:1526-1534. (Pubitemid 28354565)
31. Antonysamy MA, Fanslow WC, Fu F, et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 1999; 162:577-584. (Pubitemid 29018969)
32. Tang JL, Subbotin VM, Antonysamy MA, et al. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 2001; 72:348-350.
33. Loong CC, Hsieh HG, Lui WY, et al. Evidence for the early involvement of interleukin 17 in human and experimental renal allograft rejection. J Pathol 2002; 197:322-332.
34. Hsieh HG, Loong CC, Lui WY, et al. IL-17 expression as a possible predictive parameter for subclinical renal allograft rejection. Transpl Int 2001; 14:287-298.
35. Vanaudenaerde BM, Dupont LJ, Wuyts WA, et al. The role of interleukin-17 during acute rejection after lung transplantation. Eur Respir J 2006; 27:779-787. (Pubitemid 44914203)
36. Yoshida S, Haque A, Mizobuchi T, et al. Antitype V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well healed lung transplants. Am J Transplant 2006; 6:724-735. (Pubitemid 43345010)
37. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117:3498-3506. (Pubitemid 350097005)
38. Bobadilla JL, Love RB, Jankowska-Gan E, et al. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 2008; 177:660-668.
39. Robinson DS, O'Garra A. Further checkpoints in Th1 development. Immunity 2002; 16:755-758.
40. + T cells. Nat Immunol 2002; 3:549-557.
41. Kobayashi M, Fitz L, Ryan M, et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 1989; 170:827-845. (Pubitemid 19226667)
42. Chen Z, Tato C, Muul L, et al. Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 2007; 56:2936-2946. (Pubitemid 47502740)
43. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441:235-238.
44. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24:179-189. (Pubitemid 43214587)
45. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198:1875-1886.
46. +CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 2007; 178:6725-6729. The ability of regulatory T cells to become Th17 cells in the presence of inflammatory cytokines is reported in this study.
47. McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 2007; 8:1390-1397. Further evidence of the complex role for TGFβ in the differentiation of Th17 cells, showing that reactivated Th17 cells produce the anti-inflammatory cytokine IL-10 when TGFβ is present.
48. Jankovic D, Trinchieri G. IL-10 or not IL-10: that is the question. Nat Immunol 2007; 8:1281-1283.
49. Korn T, Bettelli E, Gao W, et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448:484-487. (Pubitemid 47123515)
50. + T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol 2007; 179:1423-1426.
51. Laurence A, Tato C, Davidson T, et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007; 26:371-381. (Pubitemid 46413906)
52. Evans HG, Suddason T, Jackson I, et al. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc Natl Acad Sci U S A 2007; 104:17034-17039. (Pubitemid 350210986)
53. Surquin M, Le Moine A, Flamand V, et al. IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts. Transplantation 2005; 80:1485-1492. (Pubitemid 41803632)
54. + Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J Immunol 2008; 181:3906-3914.
55. Acosta-Rodriguez E, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8:942-949. (Pubitemid 47300008)
56. Wilson N, Boniface K, Chan J, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8:950-957. (Pubitemid 47300009)
57. O'Garra A, Stockinger B, Veldhoen M. Differentiation of human T(H)-17 cells does require TGF-beta! Nat Immunol 2008; 9:588-590.
58. Koenen HJ, Smeets RL, Vink PM, et al. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112:2340-2352. This study demonstrates that human regulatory T cells are also capable of becoming Th17 cells under inflammatory conditions.
59. + T cell responses: the alternative approaches. Annu Rev Immunol 1997; 15:297-322.
60. Basile DP, Donohoe D, Roethe K, Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 2001; 281:887-899. (Pubitemid 33123835)
61. Rao DA, Tracey KJ, Pober JS. IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response. J Immunol 2007; 179:6536-6546.
62. + T cells via down-regulation of PI3K/Akt and NF-kappaB. Immunol Lett 2007; 108:88-96.
63. Zhang C, Zhang J, Yang B, Wu C. Cyclosporin A inhibits the production of IL-17 by memory Th17 cells from healthy individuals and patients with rheumatoid arthritis. Cytokine 2008; 42:345-352.
64. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128:1207-1211. (Pubitemid 351543220)
65. Kopf H, de la Rosa GM, Howard OM, Chen X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol 2007; 7:1819-1824. (Pubitemid 350046435)
66. O'Connor RA, Malpass KH, Anderton SM. The inflamed central nervous system drives the activation and rapid proliferation of Foxp3+ regulatory T cells. J Immunol 2007; 179:958-966.
67. StummvollGH, DiPaolo RJ, Huter EN, et al. Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J Immunol 2008; 181:1908-1916.
68. Lohr J, Knoechel B, Wang JJ, et al. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. J Exp Med 2006; 203:2785-2791. (Pubitemid 46026156)